John A. Thompson, MD, is the Medical Director of the Phase I Clinical Trials Program and Co-Director of the Melanoma Clinic at the Seattle Cancer Care Alliance. He also serves as a professor in the Medical Oncology Division at the University of Washington School of Medicine and is a member of the Clinical Research Division at Fred Hutchinson Cancer Research Center.
Dr. Thompson received his medical degree from the University of Alabama at Birmingham. He completed his internship and residency in internal medicine and his fellowship in oncology at the University of Washington. Dr. Thompson is board-certified in internal medicine and medical oncology.
Dr. Thompson is a member of several medical societies, including the American Society of Clinical Oncology, the American Association for Cancer Research, the Society for Immunotherapy of Cancer, and the National Kidney Cancer Association. He has authored or co-authored more than 150 articles, appearing in publications such as the Journal of Immunology, Blood, Leukemia, Journal of Clinical Oncology, and Clinical Cancer Research. Dr. Thompson is Vice-Chair of the NCCN Melanoma Panel. He is the co-chair of the ASCO/NCCN committee that recently published guidelines on the diagnosis and management of toxicities related to immunotherapy.